Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration. by Hiwatashi, Nao et al.
TitleAdipose-derived stem cells versus bone marrow-derived stemcells for vocal fold regeneration.
Author(s)Hiwatashi, Nao; Hirano, Shigeru; Mizuta, Masanobu; Tateya,Ichiro; Kanemaru, Shin-ichi; Nakamura, Tatsuo; Ito, Juichi




This is the peer reviewed version of the following article:
Hiwatashi, N., Hirano, S., Mizuta, M., Tateya, I., Kanemaru,
S.-i., Nakamura, T. and Ito, J. (2014), Adipose-derived stem
cells versus bone marrow-derived stem cells for vocal fold
regeneration. The Laryngoscope, 124: E461‒E469, which has
been published in final form
athttp://dx.doi.org/10.1002/lary.24816. This article may be
used for non-commercial purposes in accordance with Wiley






Adipose-derived stem cells vs. bone marrow-derived stem cells 
 for vocal fold regeneration  
 
(Abbreviation:  Comparison of ASC and BMSC) 
 
Nao Hiwatashi1, MD 
Shigeru Hirano1, MD, PhD 
Masanobu Mizuta2, 1, MD 
Ichiro Tateya1, MD, PhD 
Shin-ichi Kanemaru3, 4, 1, MD, PhD 
Tatsuo Nakamura5, MD, PhD 
Juichi Ito1, MD, PhD 
1 Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto 
University, Kyoto 
2 Department of Otolaryngology, Vanderbilt University, Nashville, TN 
3 Department of Otolaryngology, Department of Regenerative Treatment for Tympanic Membrane, 
the Foundation for Biomedical Research and Innovation 
4 Department of Otolaryngology-Head and Neck Surgery, Kitano Hospital, Tazuke Kofukai Medical 
Research Institute, Osaka 





 This study was supported by the Advanced Research for Medical Products 
Mining Program of the National Institute of Biomedical Innovation (NIBIO). 
 Presented at the 135th American Laryngological Association, Las Vegas, Nevada, 
U.S.A., May 14 – 18, 2014.  
 No financial disclosure. 
 Conflict of Interest: None 
 
Correspondence to: 
Shigeru Hirano, MD, PhD, Department of Otolaryngology-Head & Neck Surgery, 
Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. 






Objectives: Vocal fold scarring presents therapeutic challenges. Recently, cell therapy with 
mesenchymal stromal cells (MSC) has become a promising approach. The aim of this study was to 
compare the therapeutic potential of adipose-derived stem cells (ASC) with bone marrow-derived 
stem cells (BMSC) for vocal fold regeneration. 
Study Design: Prospective animal experiments with controls. 
Methods: The vocal folds of Sprague-Dawley rats were unilaterally injured. Two months after injury, 
rats were treated with a local injection of ASC (ASC group), BMSC (BMSC group) or saline 
(sham-treated group). The GFP-labeled ASC and BMSC were extracted from CAG-EGFP rats. 
Larynges were harvested for histological and immunohistochemical examinations 1 and 3 months 
post-transplantation and for quantitative real-time polymerase chain reaction (PCR) 1 month 
post-transplantation. 
Results: After 1 month, no surviving cells from the transplant were detected. Histological 
examination showed significantly increased hyaluronic acid (HA) and decreased dense collagen 
deposition in both ASC and BMSC groups compared to shams 1 and 3 months after treatment. 
Real-time PCR revealed that hyaluronan synthase 1 (Has1) and Has2 were upregulated in only the 
ASC group compared with the sham-treated group. Fibroblast growth factor 2 (basic) (Fgf2), 
hepatocyte growth factor (Hgf) and Has3 were upregulated in both cell transplantation groups. ASC 
seemed to upregulate Hgf more than did BMSC. 
Conclusions: The regenerative effects of ASC and BMSC transplantation were found to be similar 
for the restoration. It is suggested that ASC might have more potential because of better recovery of 
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Vocal fold scarring can result from injury, inflammation or surgical treatment. Vocal folds 
have multi-layered structures, including the epithelium, the superficial lamina propria (SLP), and the 
vocal ligament.1 The SLP contains a substantial amount of hyaluronic acid (HA) and its pliability is 
indispensable for the vibration of normal vocal folds and phonation. Vocal fold scarring disrupts the 
layered structures. The changes are characterized by alterations in the organization and distribution 
of extracellular matrix (ECM) components, such as the deposition of disorganized collagen and 
elastin bundles and the loss of HA.2 These histological changes stiffen the viscoelastic properties of 
vocal fold mucosa and they lead to a dysphonic, often breathy and barely sustainable voice and 
severely impact the quality of life.3  
Many therapeutic strategies have been attempted for treatment of vocal fold scarring. 
Although most of the current approaches such as collagen gel ingection,4 fat implants5 and fascia 
implants6 aim at the augmentation or softening of the scarred SLP, the degree of effectiveness varies 
between individuals and these approaches do not restore a normal ECM distribution. Recovery of the 
pliability of vocal fold and vocal function requires regulation and restoration of ECM components. 
Because of the difficulty of replacing scar tissue with innate ECM, it remains a therapeutic challenge 
in treating vocal fold scarring.7  
In recent years, stem cell-based regenerative and reparative therapies have gained 
significant attention in basic and clinical research. Mesenchymal stromal cells (MSC) have received 
much attention as a promising cell population8 because they are multipotential and capable of 
differentiating into bone, adipose, cartilage, and myelosupportive stroma in vitro and in vivo.8-10  
MSC can be derived from bone marrow (BMSC). Kanemaru et al. initially reported that injection of 
BMSC in atelocollagen gel into canine injured vocal folds improved wound healing of the vocal 
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folds in endoscopic and histological findings.11 In addition, BMSC are not immunogenic and could 
in fact be immunosuppressive.12 Although the mechanisms of immunomodulating capacity are not fully 
known, even xenograft transplantation using human BMSC have been reported to improve the 
viscoelastic and histologic properties of scarred vocal folds and/or prevented vocal fold scar 
formation.13,14 Moreover, MSC can sense inflammatory signals through the expression of 
cytokine/chemokine receptors and integrins, and migrate to sites of inflammation.15 It has been 
proven that systemically administered BMSC home to and reside at the site of injured vocal folds, 
leading to the restoration of ECM components.16 
Recent studies have reported that adult adipose tissue also contains multipotent cells and 
that these adipose-derived stem cells (ASC) have the potential for the prevention of scar formation 
or the regeneration of injured vocal folds.17,18 Lee et al. demonstrated that ASC mixed with 
atelocollagen improved the laryngoscopic findings 6 months after initial damage.16 The advantage of 
ASC over BMSC is the high abundance of the stem cell population in the fat and the ease of 
collection. It was also reported that ASC secrete multiple factors including some strong anti-fibrotic 
molecules such as hepatocyte growth factor (HGF).19 However, it has not been clarified whether 
ASC or BMSC are better suited for vocal fold regeneration. In the current study, we compared the 
potentials of ASC and BMSC for treatment of chronic vocal fold scarring, focusing on histological 




Material and Methods 
 
Animals 
In this study, we used Sprague-Dawley (SD) rats (55 males [13-weeks-old], 10 males [25-weeks-old] 
and 5 males [33-weeks-old]). We also used 8 male 13-week-old GFP transgenic Sprague-Dawley 
rats [SD-Tg(CAG-EGFP)]. All rats were purchased from Japan SLC, Inc. (Shizuoka, Japan). Animal 
care was maintained in the Institute of Laboratory Animals of the Graduate School of Medicine, 
Kyoto University. The number of animals used in this study was kept to a minimum. All possible 
efforts to reduce their suffering were made in compliance with protocols established by the Animal 
Research Committee of Kyoto University. 
 
Isolation and Cultivation of ASCs and BMSCs 
GFP transgenic rats were separated in two groups: one was for isolation of ASC (n = 4) and the other 
was for BMSC (n = 4). Rats were humanely euthanized by intra-cardiac injection of pentobarbital 
sodium (100 mg per animal; Dainippon Pharmaceutical Co. Ltd, Osaka, Japan) after inhalative 
sedation with diethyl ether. For isolation of ASC, rats’ inguinal fat pads were minced and digested in 
a lactated Ringer solution containing 0.035 mg/mL LiberaseTM, Research Grade (Roche Applied 
Science, Mannheim, Germany) under agitation for 40 min at 37°C and then rested for 5 min to 
separate the stromal cell fraction from adipocytes. The stromal cell fraction was filtered through a 
100 µm cell strainer (BD Biosciences, San Jose, CA) and centrifuged at 500 x g for 5 min. The cell 
pellet was resuspended in a lactated Ringer solution and then filtered through a 40 µm cell strainer 
(BD Biosciences). Isolated cells were seeded in flasks with Dulbecco’s modified Eagle’s medium 
(Gibco, Invitrogen Co., Carlsbad, CA) containing 10% fetal bovine serum and antibiotics. For 
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isolation of BMSC, after humanely euthanizing the animals, bilateral femurs were flushed to obtain 
bone marrow and the cells were seeded in flasks with Dulbecco’s modified Eagle’s medium 
containing 10% fetal bovine serum and antibiotics.  
 The following procedure was the same for ASC and BMSC cultivation. Cells were 
incubated in 5% CO2 at 37°C for 2 days to allow them to adhere. The medium was changed once 
daily until the cells reached confluence. Nonadherent cells were removed during the medium change, 
leaving behind only adherent ASC and BMSC. After 2 passages, the cells were collected and 
analyzed using a rat MSC functional identification kit (R&D Systems, Minneapolis, MN), 
confirming their differentiation into adipocytes, osteocytes and chondrocytes. Third- or 
fourth-passage cells were used in the following experiments. Just before transplantation, cells were 
collected and diluted to 1.0 x 107 cells/mL with phosphate-buffered saline (PBS). 
 
Surgical Procedure 
The SD rats were anesthetized with an intraperitoneal injection of ketamine hydrochloride (45 
mg/kg) and xylazine hydrochloride (4.5 mg/kg) after sedation with diethyl ether. Atropine sulfate 
(0.005 mg/kg) was also injected intraperitoneally to reduce the secretion of saliva and sputum in the 
laryngeal lumen. The animals were placed on a custom-made operating platform in a near-vertical 
position. The larynx was visualized with a rigid endoscope inserted transorally at an angle of 30°.  
The right vocal folds were injured by stripping with microscissors until the thyroarytenoid muscle 
was exposed. This surgical procedure was described previously.20 Two months after injury (animals 
were 21 weeks old), rats were again generally anesthetized as described above. After placement on 
the operating platform, a 50 µL of solution containing 5.0 x 105 GFP-labeled ASC or BMSC was 
gently injected into the right thyroarytenoid muscle adjacent to the vocal fold via a 30-gauge needle 
affixed to a microsyringe (ASC group; n = 20, BMSC group; n = 20). The remaining injured rats 
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were injected with saline (sham-treated group; n = 15). This time point of transplantation was 
selected according to the previous report that demonstrated that 2 months were required for 
maturation of the vocal fold scar in rats.20 
 The animals were euthanized as described above and each larynx was immediately 
harvested at the designated time points. The following assays were conducted. To assess 
immunohistochemical and histological changes, the ASC group and the BMSC group were sampled 
at time zero (n = 5 each), 1 month (n = 5 each) and 3 months (n = 5 each). The sham-treated group 
was assessed at 1 month (n = 5) and 3 months (n = 5).  For gene expression analysis, the ASC 
group, BMSC group and the sham-treated group were analyzed after 1 month (n = 5 each). Five 
age-matched 25-week-old SD rats served as controls for gene expression analyses. The remaining 5 
age-matched 25-week-old and 33-week-old SD rats served as controls for histological examination. 
These assessments were performed in a blinded fashion, in which the examiners were not informed 
that which rats were divided into ASC, BMSC or sham-treated group, and also into histological or 
gene expression analysis before the injection procedures. 
 
Immunohistochemical and histological examination 
The harvested larynges were fixed in 4% paraformaldehyde for 3 h, then in 30% sucrose for 24 h at 
4°C. After embedding in Optimum Cutting Temperature (O.C.T) formulation (Tissue-Tek, Kyoto, 
Japan), the samples were frozen and 10 micrometer-thick serial coronal sections were placed on 
microscope slides.  
 We performed immunohistochemical analysis to evaluate technical variations and the 
survival of injected cells. Sections were incubated in primary rabbit monoclonal antibody against 
GFP (1:200; MBL International Corp., Woburn, MA) overnight at room temperature. The samples 
were washed and incubated for 1 h at room temperature, and Alexa-Flour 488 anti-rabbit IgG (1:500; 
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Invitrogen Co., Carlsbad, CA) was used as the secondary antibody. Stained sections were visualized 
and images were captured using a BIOREVO BZ-9000 microscope (Keyence Co., Osaka, Japan). 
All images were captured at 4 - 10x magnification and the number of GFP-positive cells was 
counted from 3 different sections: anterior, middle, and posterior portions. To assess the groups that 
underwent transplantation under the same conditions at the indicated times, we compared the results 
to those obtained with the ASC group and BMSC group that were sacrificed immediately after 
transplantation (month 0). The number of GFP-positive cells was totaled in the 3 sections and the 
average was calculated. The distance between the lateral edge of the LP and the most adjacent 
transplanted cells was measured in each section and the average was also calculated.  
 We performed histological analyses to evaluate changes in the ECM or the degree of scar 
contraction of scarred vocal folds. Alcian blue staining and a hyaluronidase digestion technique were 
performed to identify HA, whereas Elastica van Gieson staining was used to measure collagen 
abundance. Images were also captured at 10x magnification with a BIOREVO BZ-9000 microscope. 
To evaluate the density of the HA or collagen area in each LP, we totaled the areas stained for HA or 
collagen in the injured right LP from the 3 sections and they were divided by the totaled whole LP 
areas. The evaluation of the density of HA or collagen area was conducted not only for the treatment 
side (right side) but the contralateral side (normal left side) as internal controls. The thickness of the 
LP was also evaluated by measuring the distances from the free edge of the vocal fold down to the 
thyroarytenoid muscle. The distances were totaled and normalized by dividing the thickness of LP of 
the normal side. 
 BIOREVO BZ-H1C and BZ-H1M software (Keyence Co.) were used to count the cells, 
and to determine areas and distances. All images were captured in the same way. These assessments 
were performed in a blinded fashion, in which the examiners were not informed of the group to 




Gene Expression Analysis 
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to examine the changes 
in mRNA expression of ECM components and endogenous growth factors induced by cell 
transplantation. Total RNA was extracted from the epithelium and LP of the right vocal fold with 
Trizol Reagent (Invitrogen Co.) following the manufacturer’s protocol. Extracted total RNA was 
quantified and qualified by measuring the A260/280 ratio of each sample. Reverse transcription was 
performed by using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA). Reactions were performed with the GeneAmp polymerase chain reaction (PCR) system 
9700 (Applied Biosystems) with the following parameters: 25°C/ten min, 48°C/30 min, 95°C/5 min 
and 4°C/5 min. 
 We examined the mRNA expression of endogenous fibroblast growth factor 2 (basic) 
(Fgf2), hepatocyte growth factor (Hgf), vascular endothelial growth factor type A (Vegfa), 
hyaluronan synthase 1 (Has1), Has2 and Has3, procollagen types I (Col1a1) and III (Col3a1), 
matrix metalloproteinase (Mmp1) and Mmp8. The primer sequences are listed in the Table. 
Amplification was performed in a 20 µL reaction mixture containing 1 µL of cDNA, 10 µL of Power 
SYBR Green Master Mix (Applied Biosystems), 0.25 µmol/L final concentration of each primer, and 
ribonuclease-free water under the following conditions: 95°C/10 min and 40 cycles of 95°C/15 s and 
60°C/1 min. Fluorescence was detected with StepOne Plus (Applied Biosystems). The specificity of 
each primer was confirmed by a single peak melting curve. From ASCs, BMSCs, sham group cells 
(1 month after cell transplantation or saline injection) and age-matched 25-week-old SD rats (normal 
control), 5 samples each were assayed and tested in triplicate. Standard curves were used and results 
are shown by the fold-change relative to the control target gene mRNA concentration normalized to 





Statistical analyses were performed using one-way factorial analysis of variance (ANOVA) followed 
by a Tukey-Kramer post hoc test for the investigation of HA and collagen ratio, the thickness of LP 
and qRT-PCR. A Student t test was used to investigate the analysis of technical variations. Statistical 
significance was defined as p < 0.01 or p < 0.05 using StatView 5.0 (SAS Institute, Berkeley, CA). 






Placement of transplanted ASC and BMSC  
To confirm the location of the transplanted cells and to demonstrate the accuracy of the injection 
procedure, we examined the placement of the injected cells just after the transplantation (month 
zero). Most of the GFP-positive transplanted cells were located within the outer space of the 
thyroarytenoid muscle (Fig. 1A). There were no distinct differences between the ASC group and the 
BMSC group in terms of the average number of cells (Fig. 1B). The average distances between the 
lateral edge of the LP and the closest transplanted cells also showed no significant differences 
between the 2 groups (Fig. 1C). Both cell numbers and distances showed normal distributions with 
the F-test conducted prior to the Student t test. 
 
Survival of Transplanted Cells 
At 1 month post-transplantation, no GFP-positive cells were detected among any sections of either 
the ASC or the BMSC group (Fig. 1A). Similarly, no cells were found to migrate or distribute in 
either the LP or underlying muscles 3 months post-transplantation. 
 
Restoration of Scarred Vocal Folds 
HA was detected by Alcian blue staining. The blue stain decolorized following hyaluronidase 
digestion. The sham-treated group showed significantly less HA, whereas in both the ASC and 
BMSC groups, HA was retained to a certain degree (Fig. 2A). The restoration of HA appeared to be 
more augmented at the anterior portions than the middle or posterior portions. The image analyses 
revealed that the density of HA-stained areas was significantly greater in ASC and BMSC groups 
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than in the sham-treated group, whereas there was no significant difference between the 2 
transplantation groups (Fig. 2B, 2C). The significant HA restorations appeared at 1 and 3 months 
post-transplantation. With Elastica van Gieson staining, severe contraction and dense collagen 
deposition were observed in the LP of the sham-treated group. On the contrary, these undesirable 
histological changes were relatively mild in the ASC and BMSC groups (Fig. 3A). Compared with 
the sham-treated group, the density of collagen-rich areas was significantly decreased in ASC and 
BMSC group 1 and 3 month post-transplantation (Fig. 3B, 3C). There was no significant difference 
between the 2 transplantation groups. For internal controls, we also calculated the density of HA and 
collagen of the contralateral side, and there were no significant differences between each group (Fig 
4A, 4B). The thickness of the LP was significantly greater in both ASC and BMSC group 1 and 3 
months post-transplantation compared with the sham-treated group (Fig. 5). The ratio of HA increase, 
collagen reduction, and the thickness of LP appeared to be slightly enhanced as time passed. No 
remarkable change was observed in the underlying muscles. 
 
Gene expression analyses 
Endogenous Fgf2 and Hgf demonstrated similar expression levels that were significantly higher in 
both the ASC and BMSC groups than in the sham-treated group, whereas the ASC group showed 
more upregulation than the BMSC group (Fig. 6).  
 As for ECM gene expression analyses, only the ASC group significantly upregulated the 
expression of Has1 and Has2 compared with the sham-treated group. Has3 was upregulated in both 
the ASC and BMSC groups. Col3a1 expression was significantly higher in the BMSC group than the 
sham-treated groups. Although the expression of Col1a1, Mmp1, Mmp8, and Vegfa was slightly 









In recent years, stem cells have received widespread attention in the fields of regenerative 
and reparative medicine, including the use of embryonic stem (ES) cells and induced pluripotent 
stem (iPS) cells. Both cell types are promising tools and could be candidates for regeneration of 
injured or diseased organs. However, there remain significant problems for clinical application, such 
as ethical issues and tumorigenicity, though efforts are being focused on finding solutions. On the 
other hand, autologous MSC are considered to be a more promising tool as they can avoid the ethical 
issues and have already been applied widely in regenerative medicine. MSC were first identified in 
bone marrow,21 and likely reside in other tissues of mesodermal origin: adipose tissue, umbilical 
cord, placenta, and dental pulp.22-25 Among these tissues, adipose tissue has the advantage of 
containing at least a thousand-fold more stem cells than does marrow26. Another advantage is easier 
accessibility. ASC are reported to have a gene expression profile similar to BMSC.27 
In the current study, we transplanted allogeneic MSC. In terms of immune rejection, 
autologous MSC might be ideal materials. However, the cell extracting procedures might be stressful 
for rats and might have some unfavorable effects on wound healing of vocal folds. We used 
allogeneic MSC based on the fact that MSC are reported to express constitutively low levels of 
cell-surface HLA class I molecules and lack expression of HLA class II leading to the absence or 
reduced activation of innate and adaptive immune responses, thus avoiding rejection of the 
allogeneic MSC.28 To identify cells, nuclear staining can be used with GFP-labeled cells to 
investigate cell survival; however, the staining dilutes out during cell proliferation. In our current 
results, the locally injected cells were not detected either in SLP or in the underlying muscles 1 
month post-transplantation. Some investigators previously reported that transplanted MSC survive in 
the injured vocal folds or its underlying muscles for 1 or 2 months post-transplantation.11,17,18 
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Kanemaru et al. also demonstrated that transplanted MSC differentiated into at least 2 lineages, 
epithelial cells and muscle.29 The differences observed in the current study might be due to the 
earlier use of a scaffold as the carrier of MSC. In this study, we simply injected cells without any 
scaffolds in order to clarify the effects achieved with a pure cell suspension. 
The histological examination demonstrated restoration of HA and reduction of collagen 
deposition in both the ASC and BMSC groups compared with the sham treated group. HA plays a 
beneficial role in maintaining ideal viscoelastic function of vocal folds,30 and increased collagen 
content in SLP correlates to the stiffness that disturbs the pliable mucosal wave.31 Such ECM repair 
might improve the mucosal wave of vibration and glottal competence. Moreover, as we showed, 
ECM restoration subsequently augmented the thickness of the SLP that would improve the glottal 
gap. In most of the specimens, the thickness of SLP seemed to be larger in the anterior portion than 
middle or posterior portion. That might come from the technical limitation because anterior portion 
of SLP is difficult to be totally resected to avoid the web formation after surgery. Apart from the 
effect on the SLP, there was no remarkable change in the underlying muscle. One reason may be due 
to the difference of intensity of injury. As we injected the cells gently, the injury that occurred in the 
muscle was relatively minor, therefore any remarkable changes such as contraction or augmentation 
were not shown.  
Although there were no significant differences in these histological findings between the 
ASC and BMSC groups, gene expression analysis revealed that only the ASC groups showed a 
significant upregulation of Has1 and Has2 compared to sham. As the upreguration of Has is closely 
related with the production of HA, the results indicated that ASC might have more potential for HA 
restoration. On the contrary, the expression of Col3a1 showed significant upregulation in the BMSC 
group compared to the sham-treated group. Collagen type III acts as a temporary scaffold converting 
to collagen type I during the wound healing process which provides long-term tensile strength to the 
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wound site and its excessive accumulation leads to a loss of vocal fold viscoelasticity. The 
expression of Mmp which reflects the collagen turnover process in tissues showed a tendency to 
increase in BMSC groups. Thus, BMSC might have more potential in the turnover of collagen. 
With regard to growth factors, both gene expression of Fgf2 and Hgf were significantly 
upregulated in both ASC and BMSC groups. The effects on Hgf seemed to be stronger in the ASC 
group than the BMSC group (ASC group, p < 0.01; BMSC group, p < 0.05, compared with the 
sham-treated group). HGF has a strong anti-fibrotic effect and it has proven to contributes to the 
prevention or complete resolution of fibrosis and improves the regeneration of some organs such as 
liver, kidney, lung, etc.32 In an in vitro model, Kumai et al. demonstrated increased HGF secretion 
from ASC when co-cultured with scarred vocal fold fibroblasts.33 HGF was also revealed to be 
effective for the treatment of chronic vocal fold scar.34 FGF2 has anti-fibrotic effects in itself and 
also stimulates the vocal fold fibroblasts to upregulate gene expression of Hgf.35 In the current study, 
considering that the injected ASC and BMSC were found to be placed neither in the SLP nor the TA 
muscle, these factors secreted from injected cells should have affected the fibroblasts of scarred 
vocal folds while the injected cells have survived, and subsequently leads to the continuous 
histological restoration and upregulation of gene expression even after the injected cells have totally 
disappeared. These paracrine effects were thought to be beneficial for vocal fold regeneration. 
 The current results indicate that ASC and BMSC have similar effects on regeneration of 
the vocal folds in terms of reconstitution of the ECM in the SLP. It is also suggested that ASC might 
have an advantage in upregulating greater secretion of HGF and HAS, which might lead to better 
regeneration of the vocal fold compared to BMSC. 
In our study, there is a limitation that the number of samples were small to exclude 
statistical issue such as type II error. Also, the observation period may not long enough in terms of 
the duration of regeneration and the safety aspect. Functional examinations are also required to 
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The current study compared regenerative effects of ASC and BMSC for scarred vocal 
folds. The results have demonstrated similar histological regeneration in both groups, while ASC 
was more effective at upregulating gene expression of Has1, Has2 and Hgf, which might indicate 
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TABLE : Primer Sequences 
Gene Forward primer Reverse primer 
Hyaluronic acid synthase 1 5'-TAGGTGCTGTTGGAGGAGATGTGA-3' 5'-AAGCTCGCTCCACATTGAAGGCTA-3' 
Hyaluronic acid synthase 2 5'-ACTGGGCAGAAGCGTGGATTATGT-3' 5'-AACACCTCCAACCATCGGGTCTTCTT-3' 
Hyaluronic acid synthase 3 5'-CCTCATCGCCACAGTCATACAA-3' 5'-CCACCAGCTGCACCGTTAGT-3' 
Procollagen type I 5'-AGGCATAAAGGGTCATCGTGGCTT-3' 5'-AGTCCATCTTTGCCAGGAGAACCA-3' 
Procollagen type III 5'-ATGAGCTTTGTGCAATGTGGGACC-3' 5'-ACTGACCAAGGTAGTTGCATCCCA-3' 
Matrix metalloproteinase 1 5'-GGTGGCCAGAATAGCTGAATG-3' 5'-GCGTTTTGATATGCCC-3' 
Matrix metalloproteinase 8 5'-CCATGGATCCAGGTTACCCCACT-3' 5'-TGTGGTCCACTGAAGAAGAGGAAGA-3' 
Fibroblast growth factor 2 5'-AAGAACGGCGGCTTCTTCCT-3' 5'-CCCTTGATGGACACAACTCC-3' 
Hepatocyte growth factor 5'-ACAAGGGCTTTCCATTCACT-3' 5'-CCAGTAGCATCGTTTTCTCG-3' 
Vascular endothelial growth factor 5'-CGTCTACCAGCGCAGCTATTG-3' 5'0-GTGAGGTTTGATCCGCATGAT-3' 
β2-microglobulin 5'-TCACACTGAATTCACACCCACCGA-3' 5'0-TGATTACATGTCTCGGTCCCAGGT-3' 






(A) Representative immunofluorescent images of GFP (green). (a, b) ASC group, (c, d) BMSC 
group: (a,c) Month zero, post-transplantation, (b,d) One month post-transplantation. LM: Left 
thyroarytenoid muscle; RM: Right thyroarytenoid muscle, *: superficial lamina propria. 
GFP-positive MSCs were located within the outer space of the thyroarytenoid muscle at month 0, 
whereas no surviving MSC were detected either in the SLP or in the underlying muscle. Scale bar = 
500 µm. (B) There were no significant differences in the average numbers of GFP-positive cells 
between the ASC group and the BMSC group at month 0. (C) There were no significant differences 
between the averaged distances between the lateral edge of LP and the most adjacent transplanted 
cells in comparisons of the ASC group and the BMSC group at month 0. 
 
Fig. 2 
(A) Representative Alcian blue staining of the normal group (a, b, c), the sham-treated group (d, e, f), 
the ASC group (g, h, i, 1 month post-transplantation; j, k, l, 3 months post-transplantation), and the 
BMSC group (m, n, o, 1 month post-transplantation; p, q, r, 3 months post-transplantation). Scale 
Bar = 200 µm. (B, C) The densities of HA-stained areas were significantly greater in the ASC and 
BMSC groups than the sham-treated group, whereas there was no significant difference between the 
2 transplantation groups. (B) One month post-transplantation, (C) Three months post-transplantation. 
*p < 0.05, **p < 0.01, one-way factorial analysis of variance with a post hoc Tukey-Kramer test. 





(A) Representative Elastica van Gieson staining of collagen in the normal group (a, b, c), the 
sham-treated group (d, e, f), the ASC group (g, h, i, 1 month post-transplantation; j, k, l, 3 months 
post-transplantation), and the BMSC group (m, n, o, 1 month post-transplantation;  p, q, r, 3 months 
post-transplantation). Scale Bar = 200 µm. (B, C) The densities of collagen-abundant areas were 
significantly decreased in the ASC and BMSC group compared to the sham-treated group, whereas 
there was no significant difference between the 2 transplantation groups. (B) One month 
post-transplantation. (C) Three months post-transplantation. *p < 0.05, **p < 0.01, one-way factorial 
analysis of variance with a post hoc Tukey-Kramer test. Bars represent the standard deviations. 
 
Fig. 4 
The densities of HA-stained areas (A) and collagen-abundant areas (B) of contralateral side (left 
uninjured side). There was no significant difference between each group at both one and three 
months post-transplantation. One-way factorial analysis of variance with a post hoc Tukey-Kramer 
test. Bars represent the standard deviations. 
 
Fig. 5 
Normalized thicknesses of lamina propria. The normalized thickness of the LP was significantly 
greater in both the ASC and BMSC groups at 1 and 3 months post-transplantation compared with the 
sham-treated group, whereas there was no significant difference between the 2 transplantation 




Gene expression ratios 1 month post-transplantation. (A, B) Significant differences were observed 
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for Has1 and Has2 in the ASC group vs. the sham-treated group. (E) Significant differences were 
observed for Col3a1 in the BMSC group vs. sham-treated group. (C, H, I) Significant differences 
were observed for Has3, Fgf2, Hgf in both the ASC and the BMSC groups vs. the sham-treated 
group. *p < 0.05, **p < 0.01, one-way factorial analysis of variance with a post hoc Tukey-Kramer 
test. Bars represent the standard deviations. 
